Hyaluronic Acid in Papillary Reconstruction (NCT02876276) | Clinical Trial Compass
CompletedPhase 4
Hyaluronic Acid in Papillary Reconstruction
15 participantsStarted 2012-11
Plain-language summary
Hyaluronic acid (HA) has been used as a dermal filler in medicine for many years. It also has umpteen benefits in terms of aiding in rapid healing and resolution of inflammation. Thus in the present study, HA has been used at the test site to fill papillary recession defects. At the control site saline was injected as the placebo.
Who can participate
Age range25 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age group of 25-75 years, with at least one pair of similar bilateral, Nordland's class I and class II loss of interdental papillae in the maxillary anterior region, radiographic evidence of sufficient interdental alveolar bone (i.e. distance between alveolar crest and contact point ≤ 5mm), pocket probing depth ≤ 4mm, systemically healthy patients, patients willing to participate in the study and patients with esthetic concerns
Exclusion Criteria:
* Patients with known allergy to hyaluronic acid, patients with poor plaque control.(≥20% O'Leary plaque index), medically compromised patients, pregnant and lactating women, history of smoking, who had received a crown or pontic on one or both teeth involved in the interproximal space, interproximal spaces next to teeth that included root grooves, furcations, Miller's tooth mobility index \>18, open contacts, probing depths \>3 mm, and radiographic evidence of pathology, with translocated or tilted teeth, and who had undergone papillary regeneration procedures in the area selected previously
What they're measuring
1
the papillary recession reduction (pRecRed).
Timeframe: 6 month
2
percentage papillary coverage(PPC
Timeframe: 6 month
Trial details
NCT IDNCT02876276
SponsorKrishnadevaraya College of Dental Sciences & Hospital